347 related articles for article (PubMed ID: 9129011)
21. Thrombotic thrombocytopenic purpura: the systemic clumping "plague".
Moake JL
Annu Rev Med; 2002; 53():75-88. PubMed ID: 11818464
[TBL] [Abstract][Full Text] [Related]
22. Platelets: thrombotic thrombocytopenic purpura.
George JN; Sadler JE; Lämmle B
Hematology Am Soc Hematol Educ Program; 2002; ():315-34. PubMed ID: 12446430
[TBL] [Abstract][Full Text] [Related]
23. Von Willebrand factor-cleaving protease activity and proteolysis of von Willebrand factor in bone marrow transplant-associated thrombotic microangiopathy.
Arai S; Allan C; Streiff M; Hutchins GM; Vogelsang GB; Tsai HM
Hematol J; 2001; 2(5):292-9. PubMed ID: 11920264
[TBL] [Abstract][Full Text] [Related]
24. Deficient activity of von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura.
Furlan M
Expert Rev Cardiovasc Ther; 2003 Jul; 1(2):243-55. PubMed ID: 15030284
[TBL] [Abstract][Full Text] [Related]
25. A perspective on the measurement of ADAMTS13 in thrombotic thrombocytopaenic purpura.
Pimanda JE; Chesterman CN; Hogg PJ
Eur J Haematol; 2003 Apr; 70(4):257-62. PubMed ID: 12656756
[TBL] [Abstract][Full Text] [Related]
26. von Willebrand factor cleaving protease (ADAMTS13) is deficient in recurrent and familial thrombotic thrombocytopenic purpura and hemolytic uremic syndrome.
Remuzzi G; Galbusera M; Noris M; Canciani MT; Daina E; Bresin E; Contaretti S; Caprioli J; Gamba S; Ruggenenti P; Perico N; Mannucci PM;
Blood; 2002 Aug; 100(3):778-85. PubMed ID: 12130486
[TBL] [Abstract][Full Text] [Related]
27. [From gene to disease; congenital thrombotic thrombocytopenic purpura due to mutations in the ADAMTS13 gene].
Schiphorst RH; van de Kar NC; van den Heuvel LP
Ned Tijdschr Geneeskd; 2003 Dec; 147(49):2422-4. PubMed ID: 14694551
[TBL] [Abstract][Full Text] [Related]
28. ADAMTS13 and TTP.
Zheng X; Majerus EM; Sadler JE
Curr Opin Hematol; 2002 Sep; 9(5):389-94. PubMed ID: 12172456
[TBL] [Abstract][Full Text] [Related]
29. The von Willebrand factor-cleaving protease (ADAMTS-13) and the diagnosis of thrombotic thrombocytopenic purpura (TTP).
Kremer Hovinga JA; Studt JD; Lämmle B
Pathophysiol Haemost Thromb; 2003 Sep-2004 Dec; 33(5-6):417-21. PubMed ID: 15692254
[TBL] [Abstract][Full Text] [Related]
30. Assays of von Willebrand factor-cleaving protease: a test for diagnosis of familial and acquired thrombotic thrombocytopenic purpura.
Furlan M; Lämmle B
Semin Thromb Hemost; 2002 Apr; 28(2):167-72. PubMed ID: 11992240
[TBL] [Abstract][Full Text] [Related]
31. Ten years of prophylactic treatment with fresh-frozen plasma in a child with chronic relapsing thrombotic thrombocytopenic purpura as a result of a congenital deficiency of von Willebrand factor-cleaving protease.
Barbot J; Costa E; Guerra M; Barreirinho MS; Isvarlal P; Robles R; Gerritsen HE; Lämmle B; Furlan M
Br J Haematol; 2001 Jun; 113(3):649-51. PubMed ID: 11380451
[TBL] [Abstract][Full Text] [Related]
32. Von Willebrand factor, ADAMTS13, and thrombotic thrombocytopenic purpura.
Tsai HM
J Mol Med (Berl); 2002 Oct; 80(10):639-47. PubMed ID: 12395148
[TBL] [Abstract][Full Text] [Related]
33. Genetic defects leading to hereditary thrombotic thrombocytopenic purpura.
Kokame K; Miyata T
Semin Hematol; 2004 Jan; 41(1):34-40. PubMed ID: 14727257
[TBL] [Abstract][Full Text] [Related]
34. Are increased levels of von Willebrand factor in chronic coronary heart disease caused by decrease in von Willebrand factor cleaving protease activity? A study by an immunoassay with antibody against intact bond 842Tyr-843Met of the von Willebrand factor protein.
He S; Cao H; Magnusson CG; Eriksson-Berg M; Mehrkash M; Schenck-Gustafsson K; Blombäck M
Thromb Res; 2001 Aug; 103(3):241-8. PubMed ID: 11672586
[TBL] [Abstract][Full Text] [Related]
35. Estimation of the von Willebrand factor-cleaving protease in plasma using monoclonal antibodies to vWF.
Obert B; Tout H; Veyradier A; Fressinaud E; Meyer D; Girma JP
Thromb Haemost; 1999 Nov; 82(5):1382-5. PubMed ID: 10595622
[TBL] [Abstract][Full Text] [Related]
36. Cloning, expression, and functional characterization of the von Willebrand factor-cleaving protease (ADAMTS13).
Plaimauer B; Zimmermann K; Völkel D; Antoine G; Kerschbaumer R; Jenab P; Furlan M; Gerritsen H; Lämmle B; Schwarz HP; Scheiflinger F
Blood; 2002 Nov; 100(10):3626-32. PubMed ID: 12393399
[TBL] [Abstract][Full Text] [Related]
37. Dissociation between the level of von Willebrand factor-cleaving protease activity and disease in a patient with congenital thrombotic thrombocytopenic purpura.
Snider CE; Moore JC; Warkentin TE; Finch CN; Hayward CP; Kelton JG
Am J Hematol; 2004 Dec; 77(4):387-90. PubMed ID: 15551280
[TBL] [Abstract][Full Text] [Related]
38. Prolonged inhibition of von Willebrand factor-cleaving protease after splenectomy in a 22-year-old patient with acute and plasma refractory thrombotic thrombocytopenic purpura.
Langer F; Bergmann F; Budde U; Hegewisch-Becker S; Hossfeld DK
Br J Haematol; 2002 Jul; 118(1):271-4. PubMed ID: 12100160
[TBL] [Abstract][Full Text] [Related]
39. Von Willebrand factor--cleaving protease activity in congenital thrombotic thrombocytopenic purpura.
Allford SL; Harrison P; Lawrie AS; Liesner R; MacKie IJ; Machin SJ
Br J Haematol; 2000 Dec; 111(4):1215-22. PubMed ID: 11167764
[TBL] [Abstract][Full Text] [Related]
40. von Willebrand factor-cleaving protease in childhood diarrhoea-associated haemolytic uraemic syndrome.
Hunt BJ; Lämmle B; Nevard CH; Haycock GB; Furlan M
Thromb Haemost; 2001 Jun; 85(6):975-8. PubMed ID: 11434704
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
